Cytoreductive surgery (CRS), also known as debulking surgery, is a surgical procedure used for ovarian cancer treatment. The main aim of this surgery is to remove as much of the visible cancer as possible, leaving behind only the microscopic residual of the tumour. This approach is often followed by therapies such as chemotherapy and enhances its effectiveness. CRS is a critical intervention that can help improve progression-free survival and overall survival rates in women with ovarian cancer.
Due to its subtle symptoms and lack of early detection, patients with ovarian cancer are often diagnosed at an advanced stage when the disease has already spread throughout the peritoneal cavity and other abdominal organs. Cytoreductive surgery is done to reduce this tumour burden to a minimal level, known as optimal cytoreduction.
Cytoreductive surgery is a complex and extensive surgery that requires meticulous planning by the surgical team.
In some cases, CRS can be combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC), where the therapy is delivered directly into the abdominal cavity to kill any remaining cancer cells.
Cytoreductive surgery is a very important aspect of the ovarian cancer treatment plan. With advancements in surgical techniques and better integration of CRS with therapies like HIPEC, survival rates and quality of life for patients can be improved.
If you or someone you know is seeking expert care for cytoreductive surgery in Hyderabad, Dr. Sravanthi Nuthalapati, a highly regarded Gynaecologist and Gynaecological Oncosurgeon, provides personalised ovarian cancer treatment in Hyderabad.
Your health and well-being are our priority. Contact us to schedule a consultation or learn more about our specialized women’s health services.
+91 7670978181
Gynaecologist & Gynaecological Oncosurgeon
Copyright © 2025 Dr. Sravanthi Nuthalapati . Designed By BrandMedix.
Contact Us